BIOPHARMA HOLDING ApS: Financial statements 2024
CVR: 35206086
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BIOPHARMA HOLDING ApS (CVR 35206086) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 921,360 and a net result of DKK -3,732,682 compared with DKK -20,576,349 the year before. That is a decrease of 3% compared with the year before. Equity in the 2024 report amounted to DKK 2,921,095. The solvency ratio was 93%.
- Gross Profit
- DKK 921,360
- Profit/Loss
- DKK -3,732,682
- Equity
- DKK 2,921,095
- Total Assets
- DKK 3,139,736
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 921K | -3.7M | 2.9M | - |
| 2023 | - | 950K | -20.6M | 108M | - |
| 2022 | - | 1.2M | -29.7M | 128.6M | - |
| 2021 | - | 704K | 12M | 158.3M | - |
| 2020 | - | 591K | 1.5M | 146.3M | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
BIOPHARMA HOLDING ApS has published its annual report for 2023. Gross profit came to DKK 950,300, and the net result was DKK -20,576,349.
About BIOPHARMA HOLDING ApS
BIOPHARMA HOLDING ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2013. The company has been dissolved on 17 July 2026. The company was registered under the industry Finansielle holdingselskaber. The company has 1 employee (2017). In 2024, the company reported a gross profit of DKK 921,360 and a net result of DKK -3,732,682 compared with DKK -20,576,349 the year before. Equity in the 2024 report amounted to DKK 2,921,095.